Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Burggraaf

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Internal Medicine|May 31, 2017
Interventions in type 2 diabetes mellitus and cardiovascular mortality-An overview of clinical trialsBenjamin Burggraaf, Manuel Castro Cabezas
Annals of Translational Medicine|December 13, 2016
Is it time to break the fast?-a paradigm shift in clinical lipidologyManuel Castro Cabezas, Benjamin Burggraaf, Boudewijn Klop
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 12, 2018
Dyslipidemias in clinical practiceManuel Castro Cabezas, Benjamin Burggraaf, Boudewijn Klop
Nutrients|May 30, 2019
Effect of Vitamin D<sub>3</sub> on the Postprandial Lipid Profile in Obese Patients: A Non-Targeted Lipidomics StudySalvador Fernández-Arroyo, Anna Hernández-Aguilera, Marijke A de Vries, et al.
Atherosclerosis|February 27, 2018
Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndromeBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Marijke A de Vries, et al.
European Journal of Clinical Investigation|December 13, 2017
Evidence for increased chylomicron remnants in rheumatoid arthritisBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Jendé van Zeben, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trialBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Marijke A de Vries, et al.
Diabetes, Obesity & Metabolism|January 9, 2020
A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitusBenjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo, et al.
European Journal of Endocrinology|March 21, 2022
Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitusBenjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo, et al.
Diabetologia|November 15, 2018
Increased NEFA levels reduce blood Mg<sup>2+</sup> in hypertriacylglycerolaemic states via direct binding of NEFA to Mg<sup>2</sup>Steef Kurstjens, Jeroen H F de Baaij, Caro Overmars-Bos, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Internal Medicine|May 31, 2017
Interventions in type 2 diabetes mellitus and cardiovascular mortality-An overview of clinical trialsBenjamin Burggraaf, Manuel Castro Cabezas
Annals of Translational Medicine|December 13, 2016
Is it time to break the fast?-a paradigm shift in clinical lipidologyManuel Castro Cabezas, Benjamin Burggraaf, Boudewijn Klop
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 12, 2018
Dyslipidemias in clinical practiceManuel Castro Cabezas, Benjamin Burggraaf, Boudewijn Klop
Nutrients|May 30, 2019
Effect of Vitamin D<sub>3</sub> on the Postprandial Lipid Profile in Obese Patients: A Non-Targeted Lipidomics StudySalvador Fernández-Arroyo, Anna Hernández-Aguilera, Marijke A de Vries, et al.
Atherosclerosis|February 27, 2018
Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndromeBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Marijke A de Vries, et al.
European Journal of Clinical Investigation|December 13, 2017
Evidence for increased chylomicron remnants in rheumatoid arthritisBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Jendé van Zeben, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trialBenjamin Burggraaf, Deborah F van Breukelen-van der Stoep, Marijke A de Vries, et al.
Diabetes, Obesity & Metabolism|January 9, 2020
A placebo-controlled proof-of-concept study of alirocumab on postprandial lipids and vascular elasticity in insulin-treated patients with type 2 diabetes mellitusBenjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo, et al.
European Journal of Endocrinology|March 21, 2022
Effects of dapagliflozin on postprandial lipid metabolism in type 2 diabetes mellitusBenjamin Burggraaf, Nadine M C Pouw, Salvador Fernández Arroyo, et al.
Diabetologia|November 15, 2018
Increased NEFA levels reduce blood Mg<sup>2+</sup> in hypertriacylglycerolaemic states via direct binding of NEFA to Mg<sup>2</sup>Steef Kurstjens, Jeroen H F de Baaij, Caro Overmars-Bos, et al.
Pageof 1